首页 | 本学科首页   官方微博 | 高级检索  
     

卵巢癌ras癌基因产物p21的定量分析
引用本文:李建峰 苏应宽. 卵巢癌ras癌基因产物p21的定量分析[J]. 癌症, 1998, 17(1): 24-25
作者姓名:李建峰 苏应宽
作者单位:[1]兰州大学生物系 [2]山东医科大学妇产科
摘    要:目的:探讨卵巢癌rasp21表达与DNA倍体水平及临床病理参数的关系。方法:采用流式免疫荧光技术。结果:36例卵巢癌14例rasp21呈阳性表达,rasp21阳性表达与组织分级无关:rasp21阳性表达量在二倍体与异倍体之间有显著性差异;rasp21阳性表达多见于粘液性卵巢癌。结论:rasp21表达量与DNA倍体相关

关 键 词:流式免疫荧光术 卵巢肿瘤 ras基因 p21基因

A quantitative analysis of the ras oncogene product p21 in ovary carcinoma
Abstract:?Purpose: To detect the relation of ras p21 expression with DNA ploidy and clinic pathological parameters. Method: By the means of flow cytometry & immunofluorescence technique. Results: There were 14 cases with ras p21 positive expression and no relationship was found between ras p21 positive expression and histopathological grade. ras p21 expression content was significantly higher in aneupolid carcinomas than that in diploid ones, ras p21 positive espression occurred frequently in mucinous carcinomas. Conclusion: The amount of ras p21 expression correlated with DNA ploidy.
Keywords:
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号